Evidence Hub

Levofloxacin-induced myopathy of the iliac and gluteal muscles

Kato Y, Tsutsumi T

BMJ case reports, 2025

1 citation

Abstract

Levofloxacin-induced myopathy is a relatively under-recognized adverse effect. Here, we present a case of myopathy affecting the iliac and gluteal muscles caused by the administration of levofloxacin. A man in the 70s was admitted to the hospital with bilateral thigh pain and difficulty walking following levofloxacin use. Creatine kinase levels were not elevated, but MRI revealed inflammation in the iliac and gluteal muscles. His symptoms improved after levofloxacin discontinuation, and he may have had levofloxacin-induced myopathy. This case report seeks to raise awareness of levofloxacin-induced myopathy by adding to the small number of reports in the literature. Levofloxacin-induced myopathy should be considered in the differential diagnosis when there are musculoskeletal symptoms in elderly patients receiving levofloxacin.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free